Cross-talk between enteric pathogens and the intestine

被引:45
作者
Uzzau, S
Fasano, A
机构
[1] Dipartimento Sci Biomed, Sez Microbiol Sperimentale & Clin, Sassari, Italy
[2] Univ Maryland, Sch Med, Ctr Vaccine Dev, Div Pediat Gastroenterol & Nutr, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Ctr Vaccine Dev, Gastrointestinal Pathophysiol Sect, Baltimore, MD 21201 USA
关键词
D O I
10.1046/j.1462-5822.2000.00041.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Enteric pathogens finely regulate the expression of virulence genes in reply to stimuli generated by the intestinal environment. This minireview focuses on recently discovered strategies developed by enteric bacteria to cause intestinal secretion through the elaboration of factors that share structure and function with specific host counterparts. Such bacterial antigens appear to interfere largely with the epithelial cell signalling that physiologically regulates the numerous and, as yet not fully elucidated, mechanisms controlling both the transcellular and the paracellular secretion pathways. Heat-stable enterotoxins (STs) elaborated by enterotoxigenic Escherichia coli and the enteroaggregative E. coli enterotoxin (EAST1) are both typical examples of enteric toxins that activate the transcellular secretion pathway by mimicking guanylin, the endogenous modulator of cGMP signalling. Alternative strategies have been developed by Salmonella to induce intestinal secretion through the elaboration of a factor (SopB) that resembles at least two of the host cell 4-phosphatases, enzymes that activate the Ca-dependent transcellular secretion pathway. Finally, Vibrio cholerae has developed innovative tactics to activate the paracellular secretion pathway through the elaboration of Zonula occludens toxin (Zot), a factor that mimics a recently described physiological modulator of intercellular tight junctions.
引用
收藏
页码:83 / 89
页数:7
相关论文
共 36 条
[1]  
Brennan P, 1999, MOL CELL BIOL, V19, P4729
[2]   THE ESCHERICHIA-COLI HEAT-STABLE ENTEROTOXIN IS A LONG-LIVED SUPERAGONIST OF GUANYLIN [J].
CARPICK, BW ;
GARIEPY, J .
INFECTION AND IMMUNITY, 1993, 61 (11) :4710-4715
[3]   A MEMBRANE FORM OF GUANYLATE-CYCLASE IS AN ATRIAL NATRIURETIC PEPTIDE RECEPTOR [J].
CHINKERS, M ;
GARBERS, DL ;
CHANG, MS ;
LOWE, DG ;
CHIN, HM ;
GOEDDEL, DV ;
SCHULZ, S .
NATURE, 1989, 338 (6210) :78-83
[4]   Cellular microbiology emerging [J].
Cossart, P ;
Boquet, P ;
Normark, S ;
Rappuoli, R .
SCIENCE, 1996, 271 (5247) :315-316
[5]   GUANYLIN - AN ENDOGENOUS ACTIVATOR OF INTESTINAL GUANYLATE-CYCLASE [J].
CURRIE, MG ;
FOK, KF ;
KATO, J ;
MOORE, RJ ;
HAMRA, FK ;
DUFFIN, KL ;
SMITH, CE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (03) :947-951
[6]   D-myo-inositol 1,4,5,6-tetrakisphosphate produced in human intestinal epithelial cells in response to Salmonella invasion inhibits phosphoinositide 3-kinase signaling pathways [J].
Eckmann, L ;
Rudolf, MT ;
Ptasznik, A ;
Schultz, C ;
Jiang, T ;
Wolfson, N ;
Tsien, R ;
Fierer, J ;
Shears, SB ;
Kagnoff, MF ;
Traynor-Kaplan, AE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) :14456-14460
[7]   Isolation and functional characterization of zonulin, a physiologic modulator of tight junctions. [J].
Fasano, A ;
Wang, W ;
Nie, W .
GASTROENTEROLOGY, 1998, 114 (04) :A1141-A1141
[8]   The enterotoxic effect of zonula occludens toxin on rabbit small intestine involves the paracellular pathway [J].
Fasano, A ;
Uzzau, S ;
Fiore, C ;
Margaretten, K .
GASTROENTEROLOGY, 1997, 112 (03) :839-846
[9]   Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model [J].
Fasano, A ;
Uzzau, S .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) :1158-1164
[10]   ZONULA OCCLUDENS TOXIN MODULATES TIGHT JUNCTIONS THROUGH PROTEIN-KINASE C-DEPENDENT ACTIN REORGANIZATION, IN-VITRO [J].
FASANO, A ;
FIORENTINI, C ;
DONELLI, G ;
UZZAU, S ;
KAPER, JB ;
MARGARETTEN, K ;
DING, X ;
GUANDALINI, S ;
COMSTOCK, L ;
GOLDBLUM, SE .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) :710-720